$CVRX

Binkowski Brent purchased $76K of CVRX

Binkowski Brent (CHIEF OPERATING OFFICER) purchased 26,223 shares of CVRx, Inc. (CVRX) at $2.91 on 2026-08-13.

Original reporting
SEC EDGAR · Binkowski Brent
Published Aug 14, 2026, 12:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CVRX
Bullish
low confidence
Mentioned
$CVRX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVRXBullishLow
01

Why it matters

The newest fact is the COO’s open-market purchase details (shares, price, total value) and the absence of a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider buy as a mild positive sentiment datapoint, but there is no fundamental update in the filing text.

03

What to watch

The article provides no context on prior insider activity, option exercises, or whether the purchase size is meaningful relative to typical insider behavior.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-13 after-hours; actionable for next-session sentiment

Background

This is an SEC Form 4 insider transaction disclosure for CVRx, Inc.

Company-level read

Ticker impact

$CVRXBullishLow confidence
Context

CVRx COO Brent Binkowski filed a Form 4 open-market purchase of 26,223 shares at $2.9147 on 2026-08-13.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless followed by additional disclosures.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying guidance, contract, or operational update in the text.

Market effects

No sector read-through is provided beyond a single insider purchase.

None indicated.

None indicated.

Counterpoint

Insider buys can be discretionary and may reflect diversification or personal liquidity needs rather than a bullish view on near-term fundamentals.

Key entities

  • CVRx, Inc.

    Company whose insider transaction was disclosed on Form 4.

  • Binkowski Brent

    Chief Operating Officer who purchased shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CVRXMedAI 8/10

CVRx (CVRX) Q2 2026 Earnings Call Transcript

CVRx (CVRX) reported Q2 2026 revenue of $15.7 million, up 16%, driven by U.S. heart failure sales. U.S. revenue rose 21% to $14.8 million; Europe revenue fell 31% to $0.9 million. Gross margin was 87%. Full-year 2026 revenue guidance was lowered to $58 million to $60 million. Management cited reimbursement headwinds, sales productivity strain, and a DOJ civil investigative demand.

$CVRXMed

CVRx, Inc. (CVRX): Results of Operations and Financial Condition

CVRx, Inc. (CVRX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CVRx Reports Second Quarter 2026 Financial and Operating Results MINNEAPOLIS, August 6, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromod